[1]赵长海,张辰铭,孙春阳,等.TP53与Wnt-5a在甲状腺癌中表达分析及临床分期的指导意义[J].医学信息,2021,34(09):1-4.[doi:10.3969/j.issn.1006-1959.2021.09.001]
　ZHAO Chang-hai,ZHANG Chen-ming,SUN Chun-yang,et al.Analysis of the Expression of TP53 and Wnt-5a in Thyroid Carcinoma and Its Clinical Stage[J].Medical Information,2021,34(09):1-4.[doi:10.3969/j.issn.1006-1959.2021.09.001]
点击复制

TP53与Wnt-5a在甲状腺癌中表达分析及临床分期的指导意义()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
34卷
期数:
2021年09期
页码:
1-4
栏目:
出版日期:
2021-05-01

文章信息/Info

Title:
Analysis of the Expression of TP53 and Wnt-5a in Thyroid Carcinoma and Its Clinical Stage
文章编号:
1006-1959（2021）09-0001-04
作者:
赵长海; 张辰铭; 孙春阳; 等
（1.佳木斯市中心医院普外科，黑龙江 佳木斯 154002； 2.佳木斯大学附属第一医院普外科，黑龙江 佳木斯 154002）
Author(s):
ZHAO Chang-hai; ZHANG Chen-ming; SUN Chun-yang; et al.
(1.Department of General Surgery,Jiamusi Central Hospital,Jiamusi 154002,Heilongjiang,China; 2.Department of General Surgery,the First Affiliated Hospital of Jiamusi University,Jiamusi 154002,Heilongjiang,China)
关键词:
甲状腺癌; 免疫组织化学; RT-PCR; TP53; Wnt-5a
Keywords:
Thyroid carcinoma; Immunohistochemistry; RT-PCR; TP53; Wnt-5a
分类号:
R736.1
DOI:
10.3969/j.issn.1006-1959.2021.09.001
文献标志码:
A
摘要:
目的 研究不同临床分期的甲状腺癌中TP53和Wnt-5a的表达特点，探讨其在甲状腺癌中表达的临床意义。方法 通过免疫组织化学技术对50例甲状腺癌组织石蜡标本和10例癌旁组织石蜡标本中TP53和Wnt-5a的表达进行检测，采用RT-PCR技术对23例手术切除的新鲜甲状腺癌组织和10例癌旁组织中TP53mRNA和Wnt-5a mRNA表达进行检测，分析其差异性。结果 TP53蛋白、mRNA在甲状腺癌组织中表达高于癌旁组织，在甲状腺癌Ⅲ~Ⅳ期的表达高于Ⅰ~Ⅱ期（P＜0.05）；Wnt-5a蛋白、mRNA在甲状腺癌表达低于癌旁组织，在甲状腺癌Ⅰ~Ⅱ期的表达高于Ⅲ~Ⅳ期（P＜0.05）；TP53和Wnt-5a基因的表达呈负相关（r=-0.720，P＜0.05）。结论 TP53和Wnt-5a基因的表达参与了甲状腺癌的发生发展，同时Wnt-5a激活的信号转导途径可能在临床甲状腺癌的治疗中具有辅助作用，二者联合检测对临床手术方式、术后治疗策略选择、预后评估具有重要的价值。
Abstract:
Objective To study the expression characteristics of TP53 and Wnt-5a in thyroid carcinoma of different clinical stages, and to explore the clinical significance of their expression in thyroid carcinoma.Methods The expression of TP53 and Wnt-5a in paraffin specimens from 50 thyroid carcinoma tissues and 10 paracarcinoma tissues were detected by immunohistochemistry.RT-PCR technology was used to detect the expression of TP53 mRNA and Wnt-5a mRNA in 23 cases of fresh thyroid carcinoma tissues and 10 cases of adjacent tissues to analyze their differences.Results The expression of TP53 protein and mRNA in thyroid carcinoma tissue was higher than that in adjacent tissues, and the expression in thyroid carcinoma stage III-IV was higher than that in stage I-II (P＜0.05);The expression of Wnt-5a protein and mRNA in thyroid carcinoma was lower than that in adjacent tissues, and the expression in thyroid carcinoma stage I-II was higher than that in stage III-IV (P＜0.05);The expression of TP53 and Wnt-5a gene was negatively correlated (r=-0.720,P＜0.05).Conclusion The expression of TP53 and Wnt-5a genes are involved in the occurrence and development of thyroid carcinoma. At the same time, the signal transduction pathway activated by Wnt-5a may play an auxiliary role in the treatment of clinical thyroid carcinoma.The combined detection of the two has important value for clinical operation methods, postoperative treatment strategy selection, and prognosis evaluation.

参考文献/References:

[1]王任飞,高再荣,欧阳伟,等.分化型甲状腺癌转移灶摄碘能力与131I清灶疗效关系的回顾性多中心研究[J].中华核医学与分子影像杂志,2020,40(6):334-338. [2]丁全全,王雁,翟渊鹏,等.分化型癌及其颈部转移淋巴结的超声诊断[J].山西医药杂志,2018,47(11):1269-1271. [3]陆琦然,刘建夏,於恩桥,等.二代测序检测乳腺癌PIK3CA、TP53、PTEN基因突变及其临床意义[J].中国现代普通外科进展,2019(7):530-535. [4]Liu J,Zhang C,Feng Z.Tumor suppressor p53 and its gain-of-function mutants in cancer[J].Acta Biochim Biophys Sin (Shanghai),2014,46(3):170-179. [5]张富宏,赵东利.甲状腺癌组织中Wnt-5a表达及对其预后的预测价值分析[J].实用癌症杂志,2019,34(11):1787-1789. [6]严丽,李清怀,冀宏,等.Wnt/β-catenin信号通路在甲状腺乳头状癌中的表达及意义[J].河北医科大学学报,2017,38(6):663-667,745. [7]刘媛超,丁汉,王义增,等.甲状腺癌AJCC/TNM分期系统第8版与第7版在分化型甲状腺癌诊治中应用比较[J].中国实用外科杂志,2018,38(6):639-642. [8]邱杰,孙莎莎,孙彦.美国癌症联合委员会第8版甲状腺癌TNM分期解读[J].山东大学耳鼻喉眼学报,2017,31(6):5-8. [9]佐晶.热休克蛋白及p53的表达与晚期卵巢浆液性腺癌预后的相关性研究[D].北京协和医学院,2016. [10]李晓庆,黄敏,陈鑫鑫,等.肺癌相关癌性脑膜炎患者脑脊液中TP53基因突变及其临床观察[J].中华医学杂志,2020,100(11):823-827. [11]刘现义,李中,王晓春,等.雄激素受体、肿瘤抑制蛋白P53在三阴性乳腺癌中的表达及其与预后的关系[J].重庆医学,2019,48(8):1412-1415. [12]张一鸣.人肝癌中p53调控的ceRNA网络分析与转录因子介导的增强子-RNA数据库构建[D].西南交通大学,2018. [13]Huang CL,Liu D,Nakano J,et al.Wnt5a expression is associated with the tumor proliferation and the stromal vascular endothelial growth factor--an expression in non-small-cell lung cancer[J].J Clin Oncol,2005,23(34):8765-8773.

相似文献/References:

[1]唐彦慧,彭子春,唐 琪.Caspase-3在不同分期翼状胬肉上皮细胞中表达的研究[J].医学信息,2018,31(03):71.[doi:10.3969/j.issn.1006-1959.2018.03.022]
　TANG Yan-hui,PENG Zi-chun,TANG Qi.Study on the Expression of Caspase-3 in Pterygium Epithelial Cells in Different Stages[J].Medical Information,2018,31(09):71.[doi:10.3969/j.issn.1006-1959.2018.03.022]
[2]王琳琳,刘 蕾.CDX2和CYP24A1在大肠癌中的表达[J].医学信息,2018,31(07):72.[doi:10.3969/j.issn.1006-1959.2018.07.023]
　WANG Lin-lin,LIU Lei.The Expression of CDX2 and CYP24A1 in Colorectal Cancer[J].Medical Information,2018,31(09):72.[doi:10.3969/j.issn.1006-1959.2018.07.023]
[3]李 科.骨形态发生蛋白4与乳腺癌骨转移的相关性研究[J].医学信息,2018,31(13):17.[doi:10.3969/j.issn.1006-1959.2018.13.005]
　LI Ke.Relationship between Bone Morphogenetic Protein 4 and Bone Metastasis in Breast Cancer[J].Medical Information,2018,31(09):17.[doi:10.3969/j.issn.1006-1959.2018.13.005]
[4]李 焰,蒲玉平,郑 轲,等.甲状腺癌术后不同时间拔除引流条的效果分析[J].医学信息,2019,32(04):116.[doi:10.3969/j.issn.1006-1959.2019.04.037]
　LI Yan,PU Yu-ping,ZHENG Ke,et al.Analysis of the Effect of Removing Drainage Strips at Different Times after Thyroid Cancer Operation[J].Medical Information,2019,32(09):116.[doi:10.3969/j.issn.1006-1959.2019.04.037]
[5]葛忠耀,田 寅,王 博,等.SIRT6和HIF-1α在三阴性乳腺癌中的表达及临床价值[J].医学信息,2019,32(05):95.[doi:10.3969/j.issn.1006-1959.2019.05.028]
　GE Zhong-yao,TIAN Yin,WANG Bo,et al.Expression and Clinical Value of SIRT6 and HIF-1α in Triple Negative Breast Cancer[J].Medical Information,2019,32(09):95.[doi:10.3969/j.issn.1006-1959.2019.05.028]
[6]柳登平,周国斌.高频超声联合多层螺旋CT在甲状腺癌诊断中的价值分析[J].医学信息,2022,35(14):141.[doi:10.3969/j.issn.1006-1959.2022.14.036]
　LIU Deng-ping,ZHOU Guo-bin.Value of High Frequency Ultrasound Combined with Multislice Spiral CT in Diagnosis of Thyroid Carcinoma[J].Medical Information,2022,35(09):141.[doi:10.3969/j.issn.1006-1959.2022.14.036]
[7]郑时玉,郭亚男.c-Met及MACC1在甲状腺乳头状癌中的表达及临床意义[J].医学信息,2022,35(15):36.[doi:10.3969/j.issn.1006-1959.2022.15.007]
　ZHENG Shi-yu,GUO Ya-nan.Expression and Clinical Significance of c-Met and MACC1 in Papillary Thyroid Carcinoma[J].Medical Information,2022,35(09):36.[doi:10.3969/j.issn.1006-1959.2022.15.007]
[8]孙 阳.甲状腺结节钙化在超声诊断甲状腺癌中的价值[J].医学信息,2019,32(24):173.[doi:10.3969/j.issn.1006-1959.2019.24.064]
　SUN Yang.The Value of Thyroid Nodule Calcification in Ultrasound Diagnosis of Thyroid Cancer[J].Medical Information,2019,32(09):173.[doi:10.3969/j.issn.1006-1959.2019.24.064]
[9]黄琪峰,郑琳琳,张 菁.甲状腺癌中miR-222关键靶基因预测及其信号通路分析[J].医学信息,2020,33(01):85.[doi:10.3969/j.issn.1006-1959.2020.01.026]
　HUANG Qi-feng,ZHENG Lin-lin,ZHANG Jing.Prediction of Key Target Genes of miR-222 in Thyroid Cancer and Analysis of Its Signal Pathway[J].Medical Information,2020,33(09):85.[doi:10.3969/j.issn.1006-1959.2020.01.026]
[10]冯 鸾,高晓洁.分化型甲状腺癌术后行131Ⅰ治疗患者自我管理效能与生命质量的相关性分析[J].医学信息,2020,33(04):184.[doi:10.3969/j.issn.1006-1959.2020.04.063]
　FENG Luan,GAO Xiao-jie.Correlation Between Self-management Efficacy and Quality of Life in Patients with Differentiated Thyroid Cancer Undergoing 131Ⅰ[J].Medical Information,2020,33(09):184.[doi:10.3969/j.issn.1006-1959.2020.04.063]

更新日期/Last Update: 1900-01-01